797 related articles for article (PubMed ID: 12169228)
1. Myotonic dystrophy: clinical and molecular parallels between myotonic dystrophy type 1 and type 2.
Ranum LP; Day JW
Curr Neurol Neurosci Rep; 2002 Sep; 2(5):465-70. PubMed ID: 12169228
[TBL] [Abstract][Full Text] [Related]
2. Myotonic dystrophy: RNA pathogenesis comes into focus.
Ranum LP; Day JW
Am J Hum Genet; 2004 May; 74(5):793-804. PubMed ID: 15065017
[TBL] [Abstract][Full Text] [Related]
3. [Myotonic dystrophy].
Nanba E
Nihon Rinsho; 2005 Mar; 63(3):429-33. PubMed ID: 15773341
[TBL] [Abstract][Full Text] [Related]
4. [Myotonic dystrophy - a new insight into a well-known disease].
Lusakowska A; Sułek-Piatkowska A
Neurol Neurochir Pol; 2010; 44(3):264-76. PubMed ID: 20625963
[TBL] [Abstract][Full Text] [Related]
5. RNA pathogenesis of the myotonic dystrophies.
Day JW; Ranum LP
Neuromuscul Disord; 2005 Jan; 15(1):5-16. PubMed ID: 15639115
[TBL] [Abstract][Full Text] [Related]
6. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
Klein AF; Gasnier E; Furling D
Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
[TBL] [Abstract][Full Text] [Related]
7. [Molecular pathways to myotonic dystrophy].
Ishiura S
Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
[TBL] [Abstract][Full Text] [Related]
8. Myotonic dystrophy type 2 and related myotonic disorders.
Meola G; Moxley RT
J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
[TBL] [Abstract][Full Text] [Related]
9. Myotonic dystrophy type 1 (DM1): a triplet repeat expansion disorder.
Kumar A; Agarwal S; Agarwal D; Phadke SR
Gene; 2013 Jun; 522(2):226-30. PubMed ID: 23570879
[TBL] [Abstract][Full Text] [Related]
10. Mice transgenic for the human myotonic dystrophy region with expanded CTG repeats display muscular and brain abnormalities.
Seznec H; Agbulut O; Sergeant N; Savouret C; Ghestem A; Tabti N; Willer JC; Ourth L; Duros C; Brisson E; Fouquet C; Butler-Browne G; Delacourte A; Junien C; Gourdon G
Hum Mol Genet; 2001 Nov; 10(23):2717-26. PubMed ID: 11726559
[TBL] [Abstract][Full Text] [Related]
11. Misregulation of alternative splicing causes pathogenesis in myotonic dystrophy.
Kuyumcu-Martinez NM; Cooper TA
Prog Mol Subcell Biol; 2006; 44():133-59. PubMed ID: 17076268
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic mechanisms of myotonic dystrophy.
Lee JE; Cooper TA
Biochem Soc Trans; 2009 Dec; 37(Pt 6):1281-6. PubMed ID: 19909263
[TBL] [Abstract][Full Text] [Related]
13. Transgenic mouse models for myotonic dystrophy type 1 (DM1).
Wansink DG; Wieringa B
Cytogenet Genome Res; 2003; 100(1-4):230-42. PubMed ID: 14526185
[TBL] [Abstract][Full Text] [Related]
14. Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy.
Wang GS; Kearney DL; De Biasi M; Taffet G; Cooper TA
J Clin Invest; 2007 Oct; 117(10):2802-11. PubMed ID: 17823658
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic RNA repeats: an expanding role in genetic disease.
Ranum LP; Day JW
Trends Genet; 2004 Oct; 20(10):506-12. PubMed ID: 15363905
[TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of a Peptide-linked morpholino oligonucleotide neutralizes mutant RNA toxicity in a mouse model of myotonic dystrophy.
Leger AJ; Mosquea LM; Clayton NP; Wu IH; Weeden T; Nelson CA; Phillips L; Roberts E; Piepenhagen PA; Cheng SH; Wentworth BM
Nucleic Acid Ther; 2013 Apr; 23(2):109-17. PubMed ID: 23308382
[TBL] [Abstract][Full Text] [Related]
17. Best practice guidelines and recommendations on the molecular diagnosis of myotonic dystrophy types 1 and 2.
Kamsteeg EJ; Kress W; Catalli C; Hertz JM; Witsch-Baumgartner M; Buckley MF; van Engelen BG; Schwartz M; Scheffer H
Eur J Hum Genet; 2012 Dec; 20(12):1203-8. PubMed ID: 22643181
[TBL] [Abstract][Full Text] [Related]
18. Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.
Meola G
Acta Myol; 2013 Dec; 32(3):154-65. PubMed ID: 24803843
[TBL] [Abstract][Full Text] [Related]
19. Myotonic dystrophy--a multigene disorder.
Larkin K; Fardaei M
Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):389-95. PubMed ID: 11719277
[TBL] [Abstract][Full Text] [Related]
20. Myotonic dystrophy type 1: role of CCG, CTC and CGG interruptions within DMPK alleles in the pathogenesis and molecular diagnosis.
Santoro M; Masciullo M; Silvestri G; Novelli G; Botta A
Clin Genet; 2017 Oct; 92(4):355-364. PubMed ID: 27991661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
